Turn Therapeutics Inc. (TTRX) — Financial statements
Income statement, balance sheet, and cash flow for Turn Therapeutics Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue & Gross Profit | ||||
| Revenue | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||
| R&D Expenses | 0.27↑8.0% | 0.25↑3179.4% | 0.01 | |
| General & Administrative Expenses | 6↑260.6% | 2↓32.6% | 2 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 6↑260.6% | 2↓32.6% | 2 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 6↑226.0% | 2↓22.1% | 2 | |
| Total Costs & Expenses | 6↑226.0% | 2↓22.1% | 2 | |
| Operating Results | ||||
| Operating Income | -6↓226.0% | -2↑22.1% | -2 | |
| Depreciation & Amortization | 0.05↑11.1% | 0.05↑8.1% | 0.04 | |
| EBITDA | -6↓231.8% | -2↑22.7% | -2 | |
| EBIT | -6↓226.0% | -2↑22.1% | -2 | |
| Interest & Other Income | ||||
| Net Interest Income | 0.03↑3.0% | 0.03↑80.8% | 0.02 | |
| Interest Income | 0.03↑3.0% | 0.03↑80.8% | 0.02 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 3↑9181.3% | 0.03↑80.8% | 0.02 | |
| Income Before Tax | -3↓80.6% | -2↑22.9% | -2 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||
| Net Income from Continuing Operations | -3↓80.6% | -2↑22.9% | -2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | |
| Net Income | -3↓80.6% | -2↑22.9% | -2 | |
| Bottom-Line Net Income | -3↓80.6% | -2↑22.9% | -2 | |
| EPS (Basic) | -0.23↓76.9% | -0.13↑23.5% | -0.17 | |
| EPS (Diluted) | -0.23↓76.9% | -0.13↑23.5% | -0.17 | |
| Weighted Average Shares | 14↑2.4% | 13↑1.3% | 13 | |
| Weighted Average Diluted Shares | 14↑2.4% | 13↑1.3% | 13 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.